Bizmoon
Grants & Loans
Regulations
Industries
Sign in
Learn more
Bizmoon

Product

  • Grants
  • Regulations
  • License checker
  • Guides
  • How it works
  • Pricing
  • Blog

Industries

  • Healthcare
  • Trade and Commerce
  • Transportation and Logistics
  • Energy and Utilities
  • Finance and Banking
  • Land and Natural Resources
  • Agriculture

Coverage

  • All grants
  • All regulations
  • Federal grants
  • Federal regulations

Company

  • Careers
  • Sign in
© 2026 BizmoonPrivacyTermsCredits
  1. Home
  2. Regulations
  3. Federal
  4. Page 10

Federal regulations

Agency
  • SEC229
  • HHS221
DOC
218
  • DOT211
  • FDA192
  • DOE160
  • DHS154
  • FERC142
  • FAA111
  • EPA92
  • DOJ73
  • NOAA68
  • USDA65
  • Treasury64
  • NIH56
  • DOL47
  • FCC29
  • SBA29
  • HUD22
  • CMS18
  • IRS16
  • FTC4
  • Recency
    • Last 30 days
    • Last 7 days
    HHSRemove filter: HHSClear all
    • Sterigenics U.S., LLC; Filing of Food Additive Petition
      June 25, 2026

      FDA received a food additive petition from Sterigenics U.S., LLC proposing ionizing radiation for pathogen reduction in raw enriched wheat flour.

    • Center for Scientific Review; Notice of Closed Meetings
      June 25, 2026

      Center for Scientific Review will hold closed meetings to review grant applications for National Institutes of Health funding across multiple scientific disciplines.

    • Center for Scientific Review; Amended Notice of Meeting
      June 25, 2026

      Center for Scientific Review announces an amended meeting notice with updated date, time, or location details for its scientific review panel proceedings.

    • National Vaccine Injury Compensation Program; List of Petitions Received
      June 25, 2026

      HRSA publishes notice of petitions received under the National Vaccine Injury Compensation Program, with the U.S. Court of Federal Claims responsible for adjudication as required by the PHS Act.

    • Master Protocols for Drug and Biological Product Development; Draft Guidance for Industry; Availability
      June 24, 2026

      FDA issues draft guidance on master protocols for drug and biological product development, clarifying design, analysis, and submission requirements for randomized trials demonstrating safety and efficacy across therapeutic areas.

    • Quantitative Systems Pharmacology (QSP)-Based Dose Selection for Minimum Anticipated Biological Effect Level (MABEL) in First-in-Human (FIH) Trials; Draft Guidance for Industry; Availability
      June 24, 2026

      FDA draft guidance recommends using quantitative systems pharmacology modeling to determine starting doses for first-in-human trials of drugs and biologics with potent pharmacological effects like cytokine release.

    • Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products; Revised Draft Guidance for Industry; Availability
      June 24, 2026

      FDA's revised draft guidance clarifies how pharmaceutical manufacturers can demonstrate substantial evidence of drug effectiveness through one adequate well-controlled clinical investigation plus confirmatory evidence, replacing 1998 standards.

    • Fiscal Year (FY) 2026 Notice of Supplemental Funding Opportunity
      June 24, 2026

      SAMHSA is providing supplemental funding up to $1,198,000 through September 29, 2029 to one eligible FY 2024 Prevention Technology Transfer Centers grant recipient for developing a substance use prevention fellowship program.

    • Medicare and State Health Care Programs: Fraud and Abuse; Request for Information Regarding the Federal Anti-Kickback Statute and Beneficiary Inducements CMP
      June 24, 2026

      The Department of Health and Human Services requests public input on whether safe harbor regulations under the Federal Anti-Kickback Statute and Beneficiary Inducements CMP need modifications for remuneration related to clinical trial participation.

    • Office of the Director, National Institutes of Health; Notice of Closed Meeting
      June 24, 2026

      National Institutes of Health Director's office will hold a closed meeting to discuss grant applications, personnel matters, and contract negotiations affecting biomedical research funding.

    PreviousPage 10 of 23 (221 total)Next

    Track Federal regulations for your business

    Tell Bizmoon what your business does and we'll cut the Federal Register down to what actually matters.

    Action items + deadlines

    Every rule is broken into specific to-dos with calendar dates.

    Affected areas

    We tell you which parts of your business each rule actually touches.

    Plain-English summaries

    Healthcare draws more federal rulemaking than any other sector

    After healthcare come the capital-heavy sectors: trade, transportation, energy, and finance. If you operate in one of them, the volume of change is relentless.

    Federal rulemaking

    • Healthcare and life sciences
    • Trade and commerce
    • Transportation and aviation
    • Energy and utilities
    • Finance
    • Natural resources
    • Other

    Browse by agency

    • CMS
    • DHS
    • DOC
    • DOE
    • DOJ
    • DOL

    Browse by state

    • Arizona
    • California
    • Colorado
    • Florida
    • Illinois
    • Kentucky

    No legal jargon. Read the impact in two sentences.

    Real-time alerts

    Email + dashboard pings the moment something changes.

    Get started free
  • DOT
  • EPA
  • FAA
  • FCC
  • FDA
  • FERC
  • FTC
  • HHS
  • HUD
  • IRS
  • NIH
  • NOAA
  • SBA
  • SEC
  • Treasury
  • USDA
  • Maryland
  • Massachusetts
  • Michigan
  • Minnesota
  • Missouri
  • New York
  • North Carolina
  • Ohio
  • Pennsylvania
  • South Carolina
  • Tennessee
  • Texas
  • Virginia
  • Washington
  • Wisconsin
  • Federal grants